Download - Weekly-equity-report by EPIC RESEARCH 11.02.13

7/29/2019 Weekly-equity-report by EPIC RESEARCH 11.02.13

1/4

WEEKLYNEWS

Fragile economy may reduce risk appetite

funds: Hindalco

Hindalco Industries' December quarter net profit f

percent to Rs 434 crore, year-on-year on higher fina

cost . The company's finance cost rose to Rs 169 c

from Rs 79 crore, YoY on account of greater ave

borrowings. D Bhattacharya, MD Hindalco spok

CNBC-TV18 regarding the result, market expectat

strategies and the challenges ahead.

GIC of Singapore picks up NTPC shares w

Rs 1,000 cr

Sovereign wealth fund GIC of Singapore has cornshares worth Rs 1,000 crore in NTPC divestme

which foreign funds bought almost 45 per cent of sh

put on sale."Foreign institutional investors have b

allocated 44.92 per cent of shares, while banks

insurance companies got allotment of 11.05 per

and 24.87 per cent, respectively," an official so

said.

Sun Pharma, Taro terminates merger deal

Taro Pharmaceutical and Sun Pharma have mut

agreed to terminate their merger agreement, announ

in August 2012, reports CNBC-TV18's Arch

Shukla.Both the companies have agreed that they

mutually terminate the merger agreement. Dispute

valuing the 33.3 percent stake remaining in Taro

minority shareholders has been the reason fo

termination of this agreement.

http://www.epicresearch.co 09752199966

WEEKLY EQUITY

NEWSLETTER11

THFEBRUARY 2013

MARKET UPDATE:-

Nifty down by 120 pts

and settle at 5903.50

Bank Nifty down by 376pts at 12280.00
http://www.epicresearch.co/http://www.epicresearch.co/http://www.epicresearch.co/


2/4

NIFTY WEEKLY PIVOTS

http://www.epicresearch.co 09752199966

MARKETANALYSIS KEY BENCHMARK INDICES EDGED LOWER IN THE WEEK ENDED FRIDAY,8FEBRUARY2013 ON

MACROECONOMIC WORRIES AFTER THE CENTRAL STATISTICS OFFICE (CSO) PROJECTED INDIA'S GDPGROWTH AT 5% FOR2012-13, THE LOWEST IN A DECADE, AND SIGNIFICANTLY LOWER THAN THE GROWRATE OF 6.2% IN 2011-12.CONCERNS THAT PSU DISINVESTMENT AND REDUCTION OF PROMOTER STAKTO MEET THE SECURITIES &EXCHANGE BOARD OF INDIA(SEBI) MANDATED MINIMUM PUBLIC

SHAREHOLDING OF 25% FOR PRIVATE COMPANIES AND 10% FOR STATE-RUN FIRMS WILL RESULT INSUPPLY OF EQUITY IN THE MARKET OVER THE NEXT FEW MONTHS ALSO WEIGHED ON THE SENTIMENT .

BSESENSEX DECLINED 296.42 POINTS OR1.5% TO 19,484.77 THE 50-UNIT S&PCNXNIFTY FELL 95.40 POINTS OR1.59% TO 5,903.50 IN THE WEEK. FROM THE 30-SHARE SENSEX PACK,23 STOCKS DECLINED . TCS ADVANCED 5.71%.TCS ON 22JANUARY2013 SAID ITS FLAGSHIP PRODUCT TCSBANCS HAS GON

LIVE IN THE UNITED STATES AT BNPPARIBAS FOR ITS CUSTODY OPERATIONS.M&M FELL 0.36%.THECOMBINED NET PROFIT OF MAHINDRA&MAHINDRA(M&M) AND ITS 100% SUBSIDIARY--MAHINDRAVEHICLE MANUFACTURERS (MVML)-- JUMPED 29.6% TO RS 915 CRORE ON 27.5% GROWTH IN GROSREVENUE PLUS OTHER INCOME TO RS 11522.30 CRORE IN Q3DECEMBER2012 OVERQ2DECEMBER2011.BHARAT HEAVYELECTRICALS (BHEL) DROPPED 7.48%.BHEL REPORTED 17.5% FALL IN NET

PROFIT TO RS 1181.85 CRORE ON 3.2%.

EXPERT OPINION

NIFTY BANK NIFTY

Nifty looks Bearish Bank Nifty looks Bearish

Strategy: Sell on rise Strategy: Sell on rise

Support:5850 Support: 12160

Resistance: 5950 Resistance: 12500

NIFTY WEEKLY PIVOTS

PIVOTS R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 6406 6251 6096 5999 5941 5844 5786 5631 5476
http://www.epicresearch.co/http://www.epicresearch.co/http://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/


3/4

://www.epicresearch.co 09752199966

NIFTY WEEKLY CHART

WEEKLY BANK NIFTY CHART
http://www.epicresearch.co/http://www.epicresearch.co/http://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/


4/4

.

GAINERS AND LOOSERS

WEEKLY NIFTY GAINERS

SCRIPS RATE VOL. (000) PR.

CLOSE

NET

CHANGE

% CHANGE

TCS 1422.60 3486.81 1387.15 35.45 2.56

Wipro 412.40 1064.71 405.70 6.70 1.65BHEL 208.75 3394.24 206.00 2.75 1.33

HDFC Bank 650.05 4706.66 641.50 8.55 1.33

L & T 1511.10 894.21 1496.40 14.70 0.98

WEEKLY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR. CLOSE NET

CHANGE

% CHANGE

Ambuja189.55 6564.25 199.95 -10.40

-5.20

Cipla 380.65 4826.51 394.10 -13.45 -3.41

Hindalco 109.70 15775.97 113.35 -3.65 -3.22

ACC 1303.75 651.48 1344.30 -40.55 -3.02

Sesa Goa 169.85 1613.89 174.40 -4.55 -2.61

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any

responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on

sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually

tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and

encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on

the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all

estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks

recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views

expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of

the information is the acceptance of this disclaimer.

All Rights Reserved.Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any

financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to

buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls

or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious

Legal Actions can be taken.